Dr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
In the last 50 years, the main approaches for treating myelodysplastic syndromes or acute myeloid leukemia have not changed. The Kousteni lab aims to change that.
As a nationally and internationally renowned lymphoma physician-scientist, Barbara Pro, MD, has dedicated her career to better understanding the disease and uncovering possible treatments.
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
While medical experts agree that women should all get screened, the age at which screening should begin is an area of controversy, leaving patients confused as to what they should do.
Almost all liver cancers develop after decades of chronic liver disease, but a new discovery by Columbia researchers, led by Robert Schwabe, MD, may lead to treatments that could break the link.
Columbia Cancer hosted high school students from the new eCLOSE summer science program who presented their research findings on the impact of nutrition in cancer development.
The CZI Diversity award recognizes the Azizi lab with a new $1.15M grant and underscores Dr. Azizi's commitment to improving diversity and inclusion in cancer science, engineering, and research.
Dr. Ghosh has been elected to the National Academy of Medicine for pioneering studies of NF-kB and establishing strategies to target NF-kB in the treating inflammatory diseases and cancer.
